Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00264394
What this trial is testing

Cardiovascular Risk Factor Management in HIV Infection

Who this might be right for
Coronary Heart DiseaseDyslipidemiaDiabetes Mellitus, Non-Insulin-Dependent+1 more
University Hospital, Basel, Switzerland 4,097
Not applicableStudy completedNCT00002157
What this trial is testing

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome

Who this might be right for
HIV InfectionsHIV Wasting Syndrome
Celgene Corporation
Post-approval studies (Phase 4)Study completedNCT00385957
What this trial is testing

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

Who this might be right for
HIV Infections
Hospital Clinic of Barcelona 70
Testing effectiveness (Phase 2)Study completedNCT00189930
What this trial is testing

An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients

Who this might be right for
HIV Infection
Bavarian Nordic 77
Testing effectiveness (Phase 2)Ended earlyNCT00040157
What this trial is testing

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

Who this might be right for
HIV Infections
Alexion Pharmaceuticals, Inc. 60
Early research (Phase 1)Study completedNCT00002180
What this trial is testing

PMPA in HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences
Not applicableStudy completedNCT02191319
What this trial is testing

Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens

Who this might be right for
HIV Infections
Boehringer Ingelheim 55
Post-approval studies (Phase 4)Study completedNCT01576731
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Not applicableStudy completedNCT02413632
What this trial is testing

Screening Strategy for Asymptomatic Sexually Transmitted Infections (STI) in a Cohort of HIV Outpatients Men Who Have Sex With Men (DRIVER)

Who this might be right for
HIV
Hopital Foch 495
Testing effectiveness (Phase 2)Study completedNCT00036634
What this trial is testing

A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients

Who this might be right for
HIV Infections
Gilead Sciences 30
Not applicableStudy completedNCT01043081
What this trial is testing

Sexually Transmitted Infections Among African American Women Who Have Sex With Women

Who this might be right for
Sexually Transmitted InfectionsHIV Infections
University of Mississippi Medical Center 300
Early research (Phase 1)Study completedNCT00000704
What this trial is testing

Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 64
Not applicableUnknownNCT03846206
What this trial is testing

Mediterranean Diet and Bacterial Translocation and Immune-activation in Patients With HIV

Who this might be right for
Hiv
Hospital Clinic of Barcelona 102
Large-scale testing (Phase 3)Study completedNCT00053638
What this trial is testing

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

Who this might be right for
HIV Infection
GlaxoSmithKline 345
Testing effectiveness (Phase 2)Looking for participantsNCT04375800
What this trial is testing

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC 84
Testing effectiveness (Phase 2)Study completedNCT00002663
What this trial is testing

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

Who this might be right for
EBV-induced LymphomasEBV-associated MalignanciesTransplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma
Atara Biotherapeutics 58
Not applicableStudy completedNCT03038724
What this trial is testing

Randomised Study Comparing Two HIV Screening Strategies

Who this might be right for
HIV Infections
University of Lausanne Hospitals 160
Not applicableUnknownNCT04044586
What this trial is testing

HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)

Who this might be right for
HIV SeropositivityHCV Infection
ANRS, Emerging Infectious Diseases 1,098
Testing effectiveness (Phase 2)Study completedNCT00592124
What this trial is testing

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 168
Large-scale testing (Phase 3)Study completedNCT00144170
What this trial is testing

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

Who this might be right for
HIV Infections
Boehringer Ingelheim 882
Next Page